STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) P/E ratio
As of 25 September 2026, STERIS plc (STE) trades at a P/E ratio of 25.4×. Over the past ten years it has ranged from 0.0× (March 2023) to 203× (June 2023); the current reading is higher than 5% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 27.8× | (23.64%) |
| FY2025 | 36.4× | (36.96%) |
| FY2024 | 57.7× | (67.11%) |
| FY2023 | 175× | 75.65% |
| FY2022 | 99.9× | 143.36% |
| FY2021 | 41.1× | 41.07% |
| FY2020 | 29.1× | (17.56%) |
| FY2019 | 35.3× | 33.02% |
| FY2018 | 26.5× | (51.10%) |
| FY2017 | 54.3× | 13.80% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 25.6× | (7.68%) |
| Mar 2026 | 27.8× | (21.21%) |
| Dec 2025 | 35.3× | (0.39%) |
| Sep 2025 | 35.4× | (3.33%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 203×
Ten-year median
38.2×
Current reading's percentile
5
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 15.3× |
| PHG Koninklijke Philips N.V. compare | 18.2× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 22.0× |
| STE STERIS plc | 25.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 32.8× |
| DXCM DexCom, Inc. compare | 33.4× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 43.8× |
| BIO Bio-Rad Laboratories, Inc. compare | 45.7× |
| PEN Penumbra, Inc. compare | 78.0× |
| Medical Devices industry median | 22.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement